Discovery and characterization of prolactin neutralizing monoclonal antibodies for the treatment of female-prevalent pain disorders.

Saved in:
Bibliographic Details
Title: Discovery and characterization of prolactin neutralizing monoclonal antibodies for the treatment of female-prevalent pain disorders.
Authors: Maciuba S; Peptide Logic, San Diego, CA, USA., Bowden GD; Peptide Logic, San Diego, CA, USA., Stratton HJ; Department of Pharmacology, The University of Arizona, Tucson, AZ, USA., Wisniewski K; Peptide Logic, San Diego, CA, USA., Schteingart CD; Peptide Logic, San Diego, CA, USA., Almagro JC; GlobalBio, Cambridge, MA, USA., Valadon P; Antibody Design Labs, San Diego, CA, USA., Lowitz J; Antibody Solutions, Santa Clara, CA, USA., Glaser SM; Peptide Logic, San Diego, CA, USA., Lee G; Department of Pharmacology, The University of Arizona, Tucson, AZ, USA., Dolatyari M; Department of Pharmacology, The University of Arizona, Tucson, AZ, USA., Navratilova E; Department of Pharmacology, The University of Arizona, Tucson, AZ, USA., Porreca F; Department of Pharmacology, The University of Arizona, Tucson, AZ, USA., Rivière PJM; Peptide Logic, San Diego, CA, USA.
Source: MAbs [MAbs] 2023 Jan-Dec; Vol. 15 (1), pp. 2254676.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101479829 Publication Model: Print Cited Medium: Internet ISSN: 1942-0870 (Electronic) Linking ISSN: 19420862 NLM ISO Abbreviation: MAbs Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1942-0870
DOI:10.1080/19420862.2023.2254676